Deutsche Märkte schließen in 4 Stunden 15 Minuten

Tandem Diabetes Care, Inc. (TNDM)

NasdaqGM - NasdaqGM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
52,81-1,94 (-3,54%)
Börsenschluss: 04:00PM EDT
53,00 +0,19 (+0,36%)
Nachbörse: 05:50PM EDT

Tandem Diabetes Care, Inc.

11075 Roselle Street
San Diego, CA 92121
United States
858 366 6900
https://www.tandemdiabetes.com

Sektor(en)Healthcare
BrancheMedical Devices
Vollzeitmitarbeiter2.000

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. John F. SheridanPres, CEO & Director1,6M1,36M1955
Ms. Leigh A. VossellerExec. VP, CFO & Treasurer764,64k5,57M1973
Mr. David B. Berger Esq.Exec. VP & COO765,11k5,62M1970
Ms. Susan M. MorrisonExec. VP & Chief Admin. Officer764,35k6,16M1979
Mr. Brian B. HansenExec. VP & Chief Commercial Officer781,22k2,26M1968
Ms. Elizabeth Anne GasserExec. VP & Chief Strategy Officer764,64k1,21M1976
Mr. Rick A. CarpenterChief Technical OfficerN/AN/A1963
Ms. Shannon M. HansenSr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.N/AN/A1966
Mr. Ross SylviaVP of MarketingN/AN/AN/A
Mr. Tom FoxSr. VP of HR & Organizational Devel.N/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2021 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:slim X2 insulin with Basal-IQ and control IQ technology; t:slim X2 with G5 Integration; and Tandem Device Updater, a tool that allows users to update their pump's software. In addition, the company offers t:connect, a web-based data management application, which provides a visual way to display diabetes therapy management data from the pump, continuous glucose monitoring, and supported blood glucose meters for users, their caregivers, and their healthcare providers; and Sugarmate, a mobile app for people with diabetes who use insulin. It has development and commercialization agreements with Dexcom, Inc. and Abbott Laboratories. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Corporate Governance

Tandem Diabetes Care, Inc.s ISS Governance QualityScore, Stand 31. Juli 2022, lautet 7. Die grundlegenden Scores sind Audit: 10, Vorstand: 5, Shareholderrechte: 6, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.